Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DH 
Definitive Healthcare Corp (DH)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/20/2025: DH (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
14 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $4.54
1 Year Target Price $4.54
| 3 | Strong Buy |
| 0 | Buy |
| 9 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -55.75% | Avg. Invested days 23 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/20/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 298.73M USD | Price to earnings Ratio - | 1Y Target Price 4.54 |
Price to earnings Ratio - | 1Y Target Price 4.54 | ||
Volume (30-day avg) 14 | Beta 1.65 | 52 Weeks Range 2.15 - 5.68 | Updated Date 10/20/2025 |
52 Weeks Range 2.15 - 5.68 | Updated Date 10/20/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -124.43% | Operating Margin (TTM) -5.76% |
Management Effectiveness
Return on Assets (TTM) -0.53% | Return on Equity (TTM) -67.34% |
Valuation
Trailing PE - | Forward PE 12.33 | Enterprise Value 340362079 | Price to Sales(TTM) 1.22 |
Enterprise Value 340362079 | Price to Sales(TTM) 1.22 | ||
Enterprise Value to Revenue 1.39 | Enterprise Value to EBITDA 46.69 | Shares Outstanding 104086210 | Shares Floating 38347441 |
Shares Outstanding 104086210 | Shares Floating 38347441 | ||
Percent Insiders 9.37 | Percent Institutions 95.92 |
Upturn AI SWOT
Definitive Healthcare Corp
Company Overview
History and Background
Definitive Healthcare Corp was founded in 2011. It evolved from a provider of healthcare provider information to an intelligence platform offering data, analytics, and expert services. It went public in September 2021.
Core Business Areas
- Information as a Service (IaaS): Provides comprehensive healthcare provider data and market intelligence.
- Software as a Service (SaaS): Delivers insights via a cloud-based platform for sales, marketing, and strategy teams.
- Analytics: Provide data insights to healthcare companies.
Leadership and Structure
Robert Musslewhite is the CEO. The company has a traditional corporate structure with functional departments and a board of directors.
Top Products and Market Share
Key Offerings
- Definitive Healthcare Platform: A SaaS platform providing healthcare commercial intelligence. It offers data on healthcare providers, affiliations, claims, and market trends. Market share data is difficult to pinpoint exactly as Definitive Healthcare operates in a fragmented market. The main competitor for this offering is ZoomInfo, Veeva Systems, and Komodo Health.
- Monocl ExpertInsight: A platform providing access to key opinion leaders and healthcare experts. This also provides data and analytics on expert networks. The main competitor for this offering is GLG (Gerson Lehrman Group), Third Bridge, and AlphaSights.
Market Dynamics
Industry Overview
The healthcare data and analytics market is growing due to the increasing need for data-driven decision-making in healthcare. Factors driving the market include regulatory changes, rising healthcare costs, and the adoption of digital health technologies.
Positioning
Definitive Healthcare is positioned as a leading provider of healthcare commercial intelligence, offering comprehensive data and analytics solutions. Its competitive advantage lies in its breadth and depth of data, integrated platform, and domain expertise.
Total Addressable Market (TAM)
The estimated TAM for healthcare commercial intelligence is over $10 billion. Definitive Healthcare is positioned to capture a significant share of this market through its product offerings and market penetration efforts.
Upturn SWOT Analysis
Strengths
- Comprehensive data coverage
- Integrated platform
- Strong customer relationships
- Experienced management team
- Scalable business model
Weaknesses
- High customer concentration
- Dependence on data quality
- Price competition
- Recent Profitability is still not strong
- Relatively new company
Opportunities
- Expansion into new markets
- Development of new products and services
- Strategic acquisitions
- Partnerships with other healthcare companies
- Growth in telemedicine and digital health
Threats
- Increased competition
- Data privacy regulations
- Economic downturn
- Rapid technological changes
- Cybersecurity risks
Competitors and Market Share
Key Competitors
- ZM
- VEEV
- IQVIA
Competitive Landscape
Definitive Healthcare competes with a range of companies, from large data providers to specialized analytics firms. Its advantages include its comprehensive data, integrated platform, and domain expertise. Its disadvantages include its smaller size and limited financial resources compared to some of its competitors.
Major Acquisitions
Trilliant Health
- Year: 2021
- Acquisition Price (USD millions): 375
- Strategic Rationale: Expanded Definitive Healthcare's market intelligence capabilities by adding healthcare provider directory and affiliation data.
Growth Trajectory and Initiatives
Historical Growth: Definitive Healthcare has experienced strong revenue growth in recent years, driven by increased demand for its products and services.
Future Projections: Future growth is projected to be driven by continued demand for healthcare commercial intelligence and expansion into new markets.
Recent Initiatives: Recent initiatives include product enhancements, strategic partnerships, and acquisitions.
Summary
Definitive Healthcare is a growing company in the healthcare commercial intelligence market, with a comprehensive data platform and strong customer relationships. While profitable, it's still in a volatile sector and the company will need to stay ahead of new competitors. Key areas to watch are customer concentration, market expansion, and new cybersecurity threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry Publications
- Third-party Market Research
Disclaimers:
This analysis is based on publicly available information and analyst estimates. It is not financial advice, and investors should conduct their own due diligence before making any investment decisions. Market share estimates are approximate.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Definitive Healthcare Corp
Exchange NASDAQ | Headquaters Framingham, MA, United States | ||
IPO Launch date 2021-09-15 | CEO & Director Mr. Kevin D. Coop | ||
Sector Healthcare | Industry Health Information Services | Full time employees 782 | Website https://www.definitivehc.com |
Full time employees 782 | Website https://www.definitivehc.com | ||
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.